These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Secondary iron overload]. Galacteros F Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():44-8. PubMed ID: 9827215 [No Abstract] [Full Text] [Related]
3. Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia. Vichinsky E Pediatrics; 2008 Jun; 121(6):1253-6. PubMed ID: 18519495 [No Abstract] [Full Text] [Related]
4. Management of iron overload in the pediatric patient. Cohen A Hematol Oncol Clin North Am; 1987 Sep; 1(3):521-44. PubMed ID: 3329185 [TBL] [Abstract][Full Text] [Related]
5. Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one? Ghosh K; Ghosh K Indian J Med Res; 2018 Oct; 148(4):369-372. PubMed ID: 30665999 [No Abstract] [Full Text] [Related]
6. HBED: A potential alternative to deferoxamine for iron-chelating therapy. Bergeron RJ; Wiegand J; Brittenham GM Blood; 1998 Feb; 91(4):1446-52. PubMed ID: 9454776 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of iron chelators in diseases associated with iron mismanagement. Weinberg ED J Pharm Pharmacol; 2006 May; 58(5):575-84. PubMed ID: 16640825 [TBL] [Abstract][Full Text] [Related]
8. [Current concepts in the management of transfusional iron overload]. Thuret I; Barlogis V; Michel G Arch Pediatr; 2009 Jun; 16(6):559-61. PubMed ID: 19541084 [No Abstract] [Full Text] [Related]
9. Iron overload and tuberculosis: a case for iron chelation therapy. Dam T Int J Tuberc Lung Dis; 2005 Aug; 9(8):942; author reply 942. PubMed ID: 16104646 [No Abstract] [Full Text] [Related]
10. Chronic iron overload: new chelators and new strategies. Fairbanks VF J Lab Clin Med; 1978 Aug; 92(2):141-3. PubMed ID: 681806 [No Abstract] [Full Text] [Related]
11. Specific chelation therapy with desferrioxamine in massive iron overdose. Levison LH Appl Ther; 1969 Mar; 11(3):153. PubMed ID: 5778632 [No Abstract] [Full Text] [Related]
12. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability. Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and treatment of iron overload in thalassemia patients in tropical countries. Marx JJ Adv Exp Med Biol; 2003; 531():57-68. PubMed ID: 12916781 [No Abstract] [Full Text] [Related]
14. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias. Ault P; Jones K Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708 [TBL] [Abstract][Full Text] [Related]
15. Deferoxamine Alleviates Iron Overload and Brain Injury in a Rat Model of Brainstem Hemorrhage. Guo X; Qi X; Li H; Duan Z; Wei Y; Zhang F; Tian M; Ma L; You C World Neurosurg; 2019 Aug; 128():e895-e904. PubMed ID: 31082547 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic application of iron chelators--present state and research trends. Peter HH J Pharmacol; 1985; 16(4):365-71. PubMed ID: 4094434 [No Abstract] [Full Text] [Related]